121 related articles for article (PubMed ID: 29677631)
1. Enhancement of monoclonal antibody production after single and combination treatment of the hybridoma cells with all-trans retinoic acid and docosahexaenoic acid: An in vitro and in vivo study.
Rokni M; Razavi AR; Shokri F; Ahmadi Kia K; Solaymani-Mohammadi F; Chahardoli R; Saboor-Yaraghi AA
Int Immunopharmacol; 2018 Jun; 59():295-300. PubMed ID: 29677631
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment of docosahexaenoic acid (DHA) and all-trans-retinoic acid (ATRA) inhibit IL-17 and RORγt gene expression in PBMCs of patients with relapsing-remitting multiple sclerosis.
Mousavi Nasl-Khameneh A; Mirshafiey A; Naser Moghadasi A; Chahardoli R; Mahmoudi M; Parastouei K; Yekaninejad MS; Saboor-Yaraghi AA
Neurol Res; 2018 Jan; 40(1):11-17. PubMed ID: 29155646
[TBL] [Abstract][Full Text] [Related]
3. Impact on monoclonal antibody production in murine hybridoma cell cultures of adenosine receptor antagonists and phosphodiesterase inhibitors.
Kelso GF; Kazi SA; Harris SJ; Boysen RI; Chowdhury J; Hearn MTW
Bioorg Med Chem Lett; 2016 Jan; 26(2):540-544. PubMed ID: 26646217
[TBL] [Abstract][Full Text] [Related]
4. The combined effects of all-trans-retinoic acid and docosahexaenoic acid on the induction of apoptosis in human breast cancer MCF-7 cells.
Abdolahi M; Shokri F; Hosseini M; Shadanian M; Saboor-Yaraghi AA
J Cancer Res Ther; 2016; 12(1):204-8. PubMed ID: 27072238
[TBL] [Abstract][Full Text] [Related]
5. Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice.
Bruce MP; Boyd V; Duch C; White JR
J Immunol Methods; 2002 Jun; 264(1-2):59-68. PubMed ID: 12191510
[TBL] [Abstract][Full Text] [Related]
6. Improved efficiency of hybridoma ascites production by intrasplenic inoculation in mice.
Witte PL; Ber R
J Natl Cancer Inst; 1983 Mar; 70(3):575-7. PubMed ID: 6339777
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory effects of all-trans retinoic acid and docosahexaenoic acid combination treatment on the expression of IL-2, IL-4, T-bet, and GATA3 genes in PBMCs of multiple sclerosis patients.
Nasl-Khameneh AM; Mirshafiey A; Moghadasi AN; Yekaninejad MS; Parastouei K; Nejati S; Saboor-Yaraghi AA
Neurol Res; 2023 Jun; 45(6):510-519. PubMed ID: 36598970
[TBL] [Abstract][Full Text] [Related]
8. A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D
Shiri-Shahsavar MR; Mirshafiee A; Parastouei K; Ebrahimi-Kalan A; Yekaninejad S; Soleymani F; Chahardoli R; Mazaheri Nezhad Fard R; Saboor-Yaraghi AA
J Mol Neurosci; 2016 Dec; 60(4):498-508. PubMed ID: 27647308
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor.
Wei M; Zhao C; Zhang S; Wang L; Liu H; Ma X
J Immunol Res; 2016; 2016():1858252. PubMed ID: 27057554
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody against human FXYD6.
Liu J; Zhou N; Zhang X
Hybridoma (Larchmt); 2011 Oct; 30(5):487-90. PubMed ID: 22008078
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody against free beta-subunit of human chorionic gonadotropin.
Baluja Conde IB; Brito Moreno AI; Acosta Bas C; Zalueta Rodríguez O; Melchor Rodríguez A; Amores Sanchéz I; Martínez L; Hernández M
Hybrid Hybridomics; 2002 Oct; 21(5):381-4. PubMed ID: 12470481
[TBL] [Abstract][Full Text] [Related]
12. Production of monoclonal antibodies for breast cancer by HB8696 hybridoma cells using novel perfusion system.
Kamthan S; Gomes J; Roychoudhury PK
Enzyme Microb Technol; 2014 Oct; 64-65():44-51. PubMed ID: 25152416
[TBL] [Abstract][Full Text] [Related]
13. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
14. Production and application of monoclonal antibody specific for human chorionic gonadotropin.
Stamenova M; Kehayov I; Kyurkchiev S; Despodova T
Folia Biol (Praha); 1990; 36(2):81-90. PubMed ID: 2192923
[TBL] [Abstract][Full Text] [Related]
15. Effect of murine ascites on the ability of hybridoma cells to produce antibody and proliferate in vitro.
Lumanglas AL; Wang BS
Hybridoma; 1993 Feb; 12(1):127-33. PubMed ID: 8454299
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibody metabolism during the growth of hybridoma cells].
Morenkov OS; Mantsygin IuA; Lezhenev EI
Tsitologiia; 1988 May; 30(5):611-5. PubMed ID: 2972097
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of hybridoma production by medium supplemented with murine ascitic fluid.
Stewart SS; Fuller SA
J Immunol Methods; 1989 Sep; 123(1):45-53. PubMed ID: 2794529
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
Salgar SK; Paape MJ; Alston-Mills B
Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
[TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1.
Okamura T; Masuda M; Arai Y; Ishida C; Shudou K; Mizoguchi H
Exp Hematol; 1998 Jun; 26(6):501-6. PubMed ID: 9620283
[TBL] [Abstract][Full Text] [Related]
20. Development of neutralizing monoclonal antibodies against VP4 of rotavirus CC0812-1.
Yang J; Wang S; Tian L; Zhang L; Li B; Dong C; Liu Z; Qi C
Hybridoma (Larchmt); 2012 Aug; 31(4):279-83. PubMed ID: 22894782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]